US23285D1090
US23285D1090
Cytek Biosciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 201.493.000 | 200.453.000 | 0.5% |
| Cost of Revenue | 97.033.000 | 89.347.000 | 8.6% |
| Gross Profit | 104.460.000 | 111.106.000 | 6.0% |
| 144.844.000 | 131.629.000 | 10.0% | |
| Operating Income | -40.384.000 | -20.523.000 | 96.8% |
| Pretax Income | -29.841.000 | -5.700.000 | 423.5% |
| Net Income Common Stockholders | -66.539.000 | -6.020.000 | 1005.3% |
| -- | -- | -- | |
| -- | -- | -- |